MPD: Phenotype measures mapped to MP:0008469, abnormal protein level

Phenotype measures associated with ontology term
MP:0008469 'abnormal protein level'

This list also includes ontology descendants of MP:0008469. Or, you can show MP:0008469 only.

This MP term has been mapped to these MPD phenotype measurements to help users find relevant data. It should be noted that MPD measurements typically have a mixture of high-end, low-end and "normal" readings.

Sort/ Pick	Data set	Procedure / Protocol	Drug or Challenge	Phenotype Measure	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Cowell1:1	Cowell1	hormone quantification	Staphylococcus aureus	fold-change in serum IL-6 levels 24h post-infection compared to controls [ratio] IL6 49001	inbred	13	f	8wks	N=3	2012

Donahue9:8	Donahue9	metabolic panel	(none)	alkaline phosphatase (serum ALP) [IU/L] ALP 41808	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9:9	Donahue9	metabolic panel	(none)	alanine transaminase (serum ALT) [IU/L] ALT 41809	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9:10	Donahue9	metabolic panel	(none)	aspartate transaminase (serum AST) [IU/L] AST 41810	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9:14	Donahue9	metabolic panel	(none)	albumin (serum Alb) [g/dL] ALB 41814	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Donahue9:16	Donahue9	metabolic panel	(none)	total protein (serum TP) [g/dL] TP 41816	B6.PWD consomic w/par	25	both	11wks	N=8	2011

Eumorphia1:1	Eumorphia1	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 23901	inbred	4	both	12wks	N=20	2007

Eumorphia1:2	Eumorphia1	metabolic panel	(none)	alkaline phosphatase (plasma ALP) [IU/L] ALP 23902	inbred	4	both	12wks	N=30	2007

Eumorphia1:3	Eumorphia1	metabolic panel	(none)	aspartate transaminase (plasma AST) [IU/L] AST 23903	inbred	4	both	12wks	N=20	2007

Eumorphia1:4	Eumorphia1	metabolic panel	(none)	creatine kinase (plasma CK) [IU/L] CK 23904	inbred	4	both	12wks	N=34	2007

Eumorphia1:17	Eumorphia1	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB 23917	inbred	6	both	12wks	N=17	2007

Eumorphia1:18	Eumorphia1	metabolic panel	(none)	plasma alpha-amylase [IU/L] amylase 23918	inbred	4	both	12wks	N=33	2007

Eumorphia1:32	Eumorphia1	metabolic panel	(none)	total protein (plasma TP) [g/dL] total 23932	inbred	6	both	12wks	N=27	2007

Farmer1:33	Farmer1	immune cell quantification	(none)	percentage of Interleukin 12 in collected blood [%] IL12 11333	QTL population		both	6wks	N=206	2001

Gros1:3	Gros1	genotype assessment	(none)	C5 allele (0=deficient, 1=sufficient) [designation] C5_allele 38503	inbred	36	f	8-12wks	N=6	2011

Harrill1:21	Harrill1	metabolic panel	isoniazid	alanine transaminase (serum ALT) [IU/L] ALT 39521 control isoniazid	inbred	34	f	8-10wks	N=4	2011

Harrill2:11	Harrill2	metabolic panel	DB289	alanine transaminase (serum ALT) [IU/L] ALT 44111 control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Jaxpheno3:10	Jaxpheno3	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB 22810 age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3:12	Jaxpheno3	metabolic panel	(none)	total protein (plasma TP) [g/dL] TP 22812 age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3:15	Jaxpheno3	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 22815 age 8wks age 16wks	inbred	11	both		N=16	2006

Jaxpheno3:17	Jaxpheno3	metabolic panel	(none)	creatine kinase (plasma CK) [IU/L] CK 22817 age 8wks age 16wks	inbred	11	both		N=16	2006

Lake1:29	Lake1	metabolic panel	(none)	aspartate transaminase (plasma AST) [mg/dL] AST 19929	B6.A consomic w/par	23	both	8wks	N=7	2005

Paigen1:24	Paigen1	metabolic panel	high-fat diet	alanine transaminase (plasma ALT) [IU/L] ALT 2924	inbred	43	both	15-19wks	N=8	2000

Paigen3:24	Paigen3	metabolic panel	high-fat diet	alanine transaminase (plasma ALT) [IU/L] ALT 2824	obesity mutants	8	both	15-19wks	N=16	2000

Peters1:25	Peters1	coagulation test	(none)	fibrinogen [mg/dL] Fib 6225	inbred w/CC7	43	both	10wks	N=10	2001

Rice1:1	Rice1	proteomic profiling	(none)	2310061N02Rik protein, spectral counts, hair proteomics 2310061N02Rik 49201	inbred	11	both	10-19wks	N=2	2012

Rice1:2	Rice1	proteomic profiling	(none)	ACGT1, spectral counts, hair proteomics Actg1 49202	inbred	11	both	10-19wks	N=2	2012

Rice1:3	Rice1	proteomic profiling	(none)	ADH6B, spectral counts, hair proteomics Adh6b 49203	inbred	11	both	10-19wks	N=2	2012

Rice1:4	Rice1	proteomic profiling	(none)	ASS1, spectral counts, hair proteomics Ass1 49204	inbred	11	both	10-19wks	N=2	2012

Rice1:5	Rice1	proteomic profiling	(none)	CAPN12, spectral counts, hair proteomics Capn12 49205	inbred	11	both	10-19wks	N=2	2012

Rice1:6	Rice1	proteomic profiling	(none)	CDSN, spectral counts, hair proteomics Cdsn 49206	inbred	11	both	10-19wks	N=2	2012

Rice1:7	Rice1	proteomic profiling	(none)	CRISP1, spectral counts, hair proteomics Crisp1 49207	inbred	11	both	10-19wks	N=2	2012

Rice1:8	Rice1	proteomic profiling	(none)	CTSB, spectral counts, hair proteomics Ctsb 49208	inbred	11	both	10-19wks	N=2	2012

Rice1:9	Rice1	proteomic profiling	(none)	DSC2, spectral counts, hair proteomics Dsc2 49209	inbred	11	both	10-19wks	N=2	2012

Rice1:10	Rice1	proteomic profiling	(none)	DUSP14, spectral counts, hair proteomics Dusp14 49210	inbred	11	both	10-19wks	N=2	2012

Rice1:11	Rice1	proteomic profiling	(none)	EEF1A1, spectral counts, hair proteomics Eef1a1 49211	inbred	11	both	10-19wks	N=2	2012

Rice1:12	Rice1	proteomic profiling	(none)	FABP4, spectral counts, hair proteomics Fabp4 49212	inbred	11	both	10-19wks	N=2	2012

Rice1:13	Rice1	proteomic profiling	(none)	FABP5, spectral counts, hair proteomics Fabp5 49213	inbred	11	both	10-19wks	N=2	2012

Rice1:14	Rice1	proteomic profiling	(none)	Gm11568, spectral counts, hair proteomics Gm11568 49214	inbred	11	both	10-19wks	N=2	2012

Rice1:17	Rice1	proteomic profiling	(none)	HIST1H2BP, spectral counts, hair proteomics Hist1h2bp 49217	inbred	11	both	10-19wks	N=2	2012

Rice1:18	Rice1	proteomic profiling	(none)	HIST1H4A, spectral counts, hair proteomics Hist1h4a 49218	inbred	11	both	10-19wks	N=2	2012

Rice1:19	Rice1	proteomic profiling	(none)	KRT16, spectral counts, hair proteomics Krt16 49219	inbred	11	both	10-19wks	N=2	2012

Rice1:20	Rice1	proteomic profiling	(none)	KRT17, spectral counts, hair proteomics Krt17 49220	inbred	11	both	10-19wks	N=2	2012

Rice1:21	Rice1	proteomic profiling	(none)	KRT31, spectral counts, hair proteomics Krt31 49221	inbred	11	both	10-19wks	N=2	2012

Rice1:22	Rice1	proteomic profiling	(none)	KRT32, spectral counts, hair proteomics Krt32 49222	inbred	11	both	10-19wks	N=2	2012

Rice1:23	Rice1	proteomic profiling	(none)	KRT75, spectral counts, hair proteomics Krt75 49223	inbred	11	both	10-19wks	N=2	2012

Rice1:24	Rice1	proteomic profiling	(none)	KRT81, spectral counts, hair proteomics Krt81 49224	inbred	11	both	10-19wks	N=2	2012

Rice1:25	Rice1	proteomic profiling	(none)	KRT82, spectral counts, hair proteomics Krt82 49225	inbred	11	both	10-19wks	N=2	2012

Rice1:26	Rice1	proteomic profiling	(none)	KRT83, spectral counts, hair proteomics Krt83 49226	inbred	11	both	10-19wks	N=2	2012

Rice1:27	Rice1	proteomic profiling	(none)	KRT84, spectral counts, hair proteomics Krt84 49227	inbred	11	both	10-19wks	N=2	2012

Rice1:28	Rice1	proteomic profiling	(none)	KRTAP3-2, spectral counts, hair proteomics Krtap3_2 49228	inbred	11	both	10-19wks	N=2	2012

Rice1:29	Rice1	proteomic profiling	(none)	KRTAP4-6, spectral counts, hair proteomics Krtap4_6 49229	inbred	11	both	10-19wks	N=2	2012

Rice1:30	Rice1	proteomic profiling	(none)	KRTAP6-2, spectral counts, hair proteomics Krtap6_2 49230	inbred	11	both	10-19wks	N=2	2012

Rice1:31	Rice1	proteomic profiling	(none)	KRTAP11-1, spectral counts, hair proteomics Krtap11_1 49231	inbred	11	both	10-19wks	N=2	2012

Rice1:32	Rice1	proteomic profiling	(none)	KRTAP13-1, spectral counts, hair proteomics Krtap13_1 49232	inbred	11	both	10-19wks	N=2	2012

Rice1:33	Rice1	proteomic profiling	(none)	KRTAP14, spectral counts, hair proteomics Krtap14 49233	inbred	11	both	10-19wks	N=2	2012

Rice1:34	Rice1	proteomic profiling	(none)	KRTAP15, spectral counts, hair proteomics Krtap15 49234	inbred	11	both	10-19wks	N=2	2012

Rice1:35	Rice1	proteomic profiling	(none)	KRTAP16-1, spectral counts, hair proteomics Krtap16_1 49235	inbred	11	both	10-19wks	N=2	2012

Rice1:36	Rice1	proteomic profiling	(none)	KRTAP19-1, spectral counts, hair proteomics Krtap19_1 49236	inbred	11	both	10-19wks	N=2	2012

Rice1:37	Rice1	proteomic profiling	(none)	KRTAP19-3, spectral counts, hair proteomics Krtap19_3 49237	inbred	11	both	10-19wks	N=2	2012

Rice1:38	Rice1	proteomic profiling	(none)	KRTAP19-4, spectral counts, hair proteomics Krtap19_4 49238	inbred	11	both	10-19wks	N=2	2012

Rice1:39	Rice1	proteomic profiling	(none)	KRTAP19-5), spectral counts, hair proteomics Krtap19_5 49239	inbred	11	both	10-19wks	N=2	2012

Rice1:40	Rice1	proteomic profiling	(none)	LGALS7, spectral counts, hair proteomics Lgals7 49240	inbred	11	both	10-19wks	N=2	2012

Rice1:41	Rice1	proteomic profiling	(none)	ME1, spectral counts, hair proteomics Me1 49241	inbred	11	both	10-19wks	N=2	2012

Rice1:42	Rice1	proteomic profiling	(none)	MLF1, spectral counts, hair proteomics Mlf1 49242	inbred	11	both	10-19wks	N=2	2012

Rice1:43	Rice1	proteomic profiling	(none)	PKP1, spectral counts, hair proteomics Pkp1 49243	inbred	11	both	10-19wks	N=2	2012

Rice1:44	Rice1	proteomic profiling	(none)	S100A3, spectral counts, hair proteomics S100a3 49244	inbred	11	both	10-19wks	N=2	2012

Rice1:45	Rice1	proteomic profiling	(none)	SFN, spectral counts, hair proteomics Sfn 49245	inbred	11	both	10-19wks	N=2	2012

Rice1:46	Rice1	proteomic profiling	(none)	TCHHL1, spectral counts, hair proteomics Tchhl1 49246	inbred	11	both	10-19wks	N=2	2012

Rice1:47	Rice1	proteomic profiling	(none)	TUBB2A, spectral counts, hair proteomics Tubb2a 49247	inbred	11	both	10-19wks	N=2	2012

Rice1:48	Rice1	proteomic profiling	(none)	VSIG8, spectral counts, hair proteomics Vsig8 49248	inbred	11	both	10-19wks	N=2	2012

RIKEN-EAD1:4	RIKEN-EAD1	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 37204	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1:5	RIKEN-EAD1	metabolic panel	(none)	aspartate transaminase (plasma AST) [IU/L] AST 37205	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1:7	RIKEN-EAD1	metabolic panel	(none)	plasma amylase [U/L] amylase 37207	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1:10	RIKEN-EAD1	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB 37210	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1:12	RIKEN-EAD1	metabolic panel	(none)	total protein (plasma TP) [g/dL] total 37212	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD1:29	RIKEN-EAD1	metabolic panel	(none)	alkaline phosphatase (plasma ALP) [IU/L] ALP 37229	inbred RBRC	35	both	8wks	N=10	2008

RIKEN-EAD2:4	RIKEN-EAD2	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 37804	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2:5	RIKEN-EAD2	metabolic panel	(none)	aspartate transaminase (plasma AST) [IU/L] AST 37805	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2:7	RIKEN-EAD2	metabolic panel	(none)	plasma amylase [U/L] amylase 37807	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2:10	RIKEN-EAD2	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB 37810	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2:12	RIKEN-EAD2	metabolic panel	(none)	total protein (plasma TP) [g/dL] total 37812	wild-derived RBRC	26	both	8wks	N=12	2008

RIKEN-EAD2:29	RIKEN-EAD2	metabolic panel	(none)	alkaline phosphatase (plasma ALP) [IU/L] ALP 37829	wild-derived RBRC	26	both	8wks	N=12	2008

Rusyn2:11	Rusyn2	metabolic panel	(none)	alanine transaminase (serum ALT), naive [IU/L] ALT 36111	inbred	16	m	7wks	N=3	2010

Rusyn2:12	Rusyn2	metabolic panel	trichloroethylene	alanine transaminase (serum ALT), control group [IU/L] ALT_ctrl 36112 time: 2h 8h 24h	inbred	16	m	7wks	N=3	2010

Rusyn2:17	Rusyn2	metabolic panel	trichloroethylene	alanine transaminase (serum ALT), treated group [IU/L] ALT_tce 36117 time: 2h 8h 24h	inbred	16	m	7wks	N=3	2010

Rusyn2:21	Rusyn2	metabolic panel	(none)	aspartate transaminase (serum AST), naive [IU/L] AST 36121	inbred	15	m	7wks	N=3	2010

Rusyn2:22	Rusyn2	metabolic panel	trichloroethylene	aspartate transaminase (serum AST), control group [IU/L] AST_ctrl 36122 time: 2h 8h 24h	inbred	15	m	7wks	N=3	2010

Rusyn2:27	Rusyn2	metabolic panel	trichloroethylene	aspartate transaminase (serum AST), treated group [IU/L] AST_tce 36127 time: 2h 8h 24h	inbred	15	m	7wks	N=3	2010

Rusyn5:1	Rusyn5	metabolic panel	high-fat diet and ethanol	serum alanine transaminase (ALT) [IU/L] ALT 43001 high-fat only high-fat and ethanol	inbred	14	m	8-14wks	N=3	2011

Rusyn5:44	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver DDIT3 (formerly CHOP), protein expression relative to high-fat-only group [%] liver_DDIT3_hfe 43044	inbred	14	m	8-14wks	N=3	2011

Rusyn5:46	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver HSPA5 (formerly GRP78), protein expression relative to high-fat-only group [%] liver_HSPA5_hfe 43046	inbred	14	m	8-14wks	N=3	2011

Rusyn5:48	Rusyn5	metabolite quantification	high-fat diet and ethanol	liver SREBF1 (formerly NSREBP1), protein expression relative to high-fat-only group [%] liver_SREBF1_hfe 43048	inbred	14	m	8-14wks	N=3	2011

Rusyn6:55	Rusyn6	histopathology	trichloroethylene	kidney injury molecule 1 (KIM-1) positive proximal tubules [%] KIM1_kidney 51255 control TCE	inbred	7	m	6-7wks	N=4	2014

Shockley1:4	Shockley1	metabolic panel	high-fat diet	glutamate dehydrogenase (GLDH) [IU/L] GLDH 33404 control diet high-fat diet difference	inbred	10	both	10-13wks	N=5	2008

Svenson3:41	Svenson3	coagulation test	(none)	antithrombin III (AT III) anticlotting factor, percentage of normal human value [%] AT3 27341	B6.PWD consomic w/par	22	both	6wks	N=8	2006

Svenson3:42	Svenson3	coagulation test	(none)	clotting factor VIII, percent of normal human value [%] F8 27342	B6.PWD consomic w/par	21	both	6wks	N=8	2006

Svenson3:43	Svenson3	coagulation test	(none)	blood fibrinogen [mg/dL] Fib 27343	B6.PWD consomic w/par	23	both	6wks	N=8	2006

Svenson3:67	Svenson3	metabolic panel	(none)	aspartate transaminase (plasma AST) [mg/dL] AST 27367	B6.PWD consomic w/par	21	both	8wks	N=7	2006

Threadgill1:6	Threadgill1	metabolic panel	acetaminophen	alanine transaminase (serum ALT) [IU/L] ALT_ctrl 19406	inbred w/CC7	37	m	8-17wks	N=2	2005

Threadgill1:7	Threadgill1	metabolic panel	acetaminophen	alanine transaminase (serum ALT), t=4h [IU/L] ALT_Rx100_4h 19407	inbred w/CC7	7	m	8-17wks	N=4	2005

Threadgill1:8	Threadgill1	metabolic panel	acetaminophen	alanine transaminase (serum ALT), t=12h [IU/L] ALT_Rx100_12h 19408	inbred w/CC7	7	m	8-17wks	N=4	2005

Threadgill1:9	Threadgill1	metabolic panel	acetaminophen	alanine transaminase (serum ALT), t=24h [IU/L] ALT_Rx100_24h 19409	inbred w/CC7	7	m	8-17wks	N=3	2005

Threadgill1:10	Threadgill1	metabolic panel	acetaminophen	aspartate transaminase (serum AST) [IU/L] AST 19410 dose (mg/kg): control 100 200 300	inbred w/CC7	37	m	8-17wks	N=2	2005

Threadgill1:83	Threadgill1	biomarker quantification	acetaminophen	cytochrome P450 1A2 isoform [pmol/mg] CYP1A2 19483 control post-Rx 300 mg/kg	inbred w/CC7	36	m	8-12wks	N=2	2005

Threadgill1:84	Threadgill1	biomarker quantification	acetaminophen	cytochrome P450 2E1 isoform [pmol/mg] CYP2E1 19484 control post-Rx 300 mg/kg	inbred w/CC7	37	m	8-12wks	N=2	2005

Threadgill2:2	Threadgill2	metabolic panel	acetaminophen	alanine transaminase (serum ALT) [IU/L] ALT 39602 50 mg/kg 300 mg/kg	inbred	5	m	6-8wks	N=5	2005

Tomasini1:1	Tomasini1	biomarker quantification	(none)	fibronectin [µg/mL] fibronectin 26101	inbred	24	both	9wks	N=8	2007

Wiltshire3:1	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex ACTH, relative fluorescence intensity ACTH 38101 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:4	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex APOD, relative fluorescence intensity APOD 38104 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:7	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex BAG1, relative fluorescence intensity BAG1 38107 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:10	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex BDNF, relative fluorescence intensity BDNF 38110 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:13	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex CREB1 (CREB), relative fluorescence intensity CREB1 38113 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:16	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex FOS (c-fos), relative fluorescence intensity FOS 38116 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:19	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex FUT9, relative fluorescence intensity FUT9 38119 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:22	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GAD1 (GAD67), relative fluorescence intensity GAD1 38122 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:25	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GAL, relative fluorescence intensity GAL 38125 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:28	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GFAP, relative fluorescence intensity GFAP 38128 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:31	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GHRL, relative fluorescence intensity GHRL 38131 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:34	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GIRK3 (KCNJ9), relative fluorescence intensity GIRK3 38134 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:37	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GLO1, relative fluorescence intensity GLO1 38137 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:40	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GNB1, relative fluorescence intensity GNB1 38140 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:43	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GRIN1 (NMDA1), relative fluorescence intensity GRIN1 38143 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:46	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GSK3B, relative fluorescence intensity GSK3B 38146 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:49	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex GSR, relative fluorescence intensity GSR 38149 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:52	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex HDAC5, relative fluorescence intensity HDAC5 38152 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:55	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex NGF, relative fluorescence intensity NGF 38155 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:58	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex NPY, relative fluorescence intensity NPY 38158 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:61	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex P2RX7 (P2X7), relative fluorescence intensity P2RX7 38161 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:64	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex PAQR8, relative fluorescence intensity PAQR8 38164 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:67	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex PPP1R1B, relative fluorescence intensity PPP1R1B 38167 control fluoxetine	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:70	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex PTH, relative fluorescence intensity PTH 38170 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:73	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex S100B, relative fluorescence intensity S100B 38173 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:76	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex SCG5 (SGNE), relative fluorescence intensity SCG5 38176 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:79	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex SLC6A2 (NET), relative fluorescence intensity SLC6A2 38179 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:82	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex SLC6A4 (SERT), relative fluorescence intensity SLC6A4 38182 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:85	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex SST, relative fluorescence intensity SST 38185 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:88	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex TNF (TNFa), relative fluorescence intensity TNF 38188 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:91	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex VEGFA (VEGF), relative fluorescence intensity VEGFA 38191 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Yuan3:1	Yuan3	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 24401 6mo 12mo 18mo	inbred	29	both		N=6	2008

Yuan3:11	Yuan3	metabolic panel	(none)	alkaline phosphatase (serum ALP) [IU/L] ALP 24411 6mo 12mo 18mo	inbred	28	both		N=7	2008

Yuan3:51	Yuan3	metabolic panel	(none)	albumin (plasma Alb) [g/dL] ALB 24451 6mo 12mo 18mo	inbred	29	both		N=6	2008

Yuan3:56	Yuan3	metabolic panel	(none)	total protein (plasma TP) [g/dL] TP 24456 6mo 12mo 18mo	inbred	29	both		N=7	2008